Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis: a Prospective Cohort Study

NCT04543643 is registered in ClinicalTrials.gov with Tianjin Second People's Hospital as lead sponsor.

NCT NCT04543643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04543643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis: a Prospective Cohort Study
Lead sponsor
Tianjin Second People's Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
November 1, 2021
Completion date
October 31, 2023
Enrollment
288 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis due to hepatitis b, cirrhosis due to hepatitis c, gastroesophageal varices